Haryana government has ordered a halt of total production of cough syrups from Sonipat-based company Maiden Pharmaceuticals Limited, which was recently flagged by the World Health Organisation (WHO) following the deaths of 66 children in The Gambia.
The company has also been issued a show cause notice for 12 violations found at its manufacturing plant. State health minister Anil Vij told ANI on Wednesday, “The samples of three drugs of the Sonipat-based pharmaceutical company which were mentioned by WHO, have been sent to Central Drug Laboratory in Kolkata. The report is yet to come. We will take action only after the report comes. After a joint inspection by Central and State officials, 12 violations were found in the manufacturing facility. … It has been decided to shut total production. We have sent a notice in this regard.”
The pharma company had come under scanner following the death of 66 children who had consumed the cough syrup in The Gambia. World Health Organization (WHO) on October 5 issued a medical product alert over four India-made cough and cold syrups manufactured by Maiden Pharmaceuticals. WHO has also notified that the same cough and cold syrups could be linked to deaths of 66 children in The Gambia.
